loader image
Monday, December 22, 2025
78.3 F
McAllen
- Advertisement -

Fasting Vs. Calorie Restriction

Which is more effective at reducing blood sugar levels?

Health & Lifestyle
470

Listen to article (english)

Translate to Spanish or other 102 languages!

Researchers compared the effects of time-restricted intermittent fasting, caloric restriction, and a weight loss booklet on weight loss. Image for illustration purposes
Researchers compared the effects of time-restricted intermittent fasting, caloric restriction, and a weight loss booklet on weight loss. Image for illustration purposes

Mega Doctor News

- Advertisement -
  • Researchers compared the effects of time-restricted intermittent fasting, caloric restriction, and a weight loss booklet on weight loss.
  • They found that time-restricted intermittent fasting reduced blood sugar levels and increased insulin sensitivity more than the other methods. 
  • Further research may refine how time-restricted intermittent fasting may be used to manage type 2 diabetes. 

Type 2 diabetes (T2D) is a condition that affects how the body uses glucose for energy. Over time, T2D can damage nerves and blood vessels. More than 37 million AmericansTrusted Source have the condition.

Follow the link below to read he full story on Medical News Today:

https://www.medicalnewstoday.com/articles/intermittent-fasting-vs-calorie-restriction-t2d-blood-sugar-levels?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-04-20&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: 

https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Staying Healthy Around Backyard Poultry
Next article
Why Staring at Screens Can Cause Migraines

More Articles

6 Depression Symptoms in Midlife Linked to Almost 50% Higher Dementia Risk

In 2021, about 57 million people globally were living with dementia — an umbrella term for neurological conditions that impact a person’s cognitive skills and memory, such as Alzheimer’s disease and vascular dementia

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© Mega Doctor News 2025

×